Johnson & Johnson (JNJ) Dividend Coverage Ratio Growth (5y) (2014 - 2026)
Powered by 
Analysis
Johnson & Johnson (JNJ) Dividend Coverage Ratio Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.24 Bn | 625.48 Bn | 17.26 Bn |
| 2 | AbbVie | 441.52 Bn | 434.96 Bn | 12.70 Bn |
| 3 | Merck | 365.75 Bn | 358.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.61 Bn | 258.92 Bn | 11.24 Bn |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.43 Bn | 18.77 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -5.28% |
| Mar 29, 2026 | -6.43% |
| Dec 28, 2025 | 20.10% |
| Sep 28, 2025 | 4.24% |
| Jun 29, 2025 | 5.35% |
| Mar 30, 2025 | 9.72% |
| Dec 29, 2024 | -6.44% |
| Sep 29, 2024 | 5.17% |
| Jun 30, 2024 | -6.72% |
| Mar 31, 2024 | -6.23% |
| Dec 31, 2023 | 2.29% |
| Oct 1, 2023 | 40.96% |
| Jul 2, 2023 | 0.32% |
| Apr 2, 2023 | -15.01% |
| Jan 1, 2023 | 16.87% |
| Apr 3, 2022 | -2.24% |
| Apr 4, 2021 | 1.59% |
| Sep 27, 2020 | -3.74% |
| Jun 28, 2020 | -8.89% |
| Mar 29, 2020 | 0.83% |